|
|
|
|
An Integrated Safety and Efficacy Analysis of Sofosbuvir-Based Regimens in Patients With Hereditary Bleeding Disorders
|
|
|
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
K. Rajender Reddy,1 Catherine Stedman,2 Kimberly Workowski,3 Jenny C. Yang,4 Luisa M. Stamm,4 Ming Lin,4 Diana M. Brainard,4 John G. McHutchinson,4 Gayle P. Balba,5 Edward J. Gane,6 Christopher Walsh7
1University of Pennsylvania, Philadelphia, USA; 2Christchurch Clinical Studies Trust, Christchurch, New Zealand; 3Emory University, Atlanta, Georgia, USA; 4Gilead Sciences, Inc., Foster City, California, USA; 5MedStar Georgetown University Hospital, Washington, DC, USA; 6Auckland Clinical Studies, Auckland, New Zealand; 7Mount Sinai Hospital, New York, New York, USA
|
|
|
|
|
|
|